Two Sigma Investments, LP Assembly Biosciences, Inc. Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.65 - $1.25 $87,781 - $168,810	135,048 New	135,048 $110,000
Q1 2023 May 15, 2023	BUY	$0.8 - $1.74 $30,642 - $66,647	38,303 New	38,303 $32,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.34 $51,630 - $71,068	-30,371 Reduced 48.64%	32,067 $53,000
Q2 2022 Aug 15, 2022	BUY	$1.35 - $2.29 $84,291 - $142,983	62,438 New	62,438 $131,000
Q1 2022 May 16, 2022	SELL	$1.46 - $2.45 $277,824 - $466,212	-190,291 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$2.13 - $3.46 $405,319 - $658,406	190,291 New	190,291 $443,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $2.03 Million - $2.52 Million	-646,318 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.8 - $4.56 $351,587 - $421,904	92,523 Added 16.71%	646,318 $2.51 Million
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $2.4 Million - $3.67 Million	553,795 New	553,795 $2.55 Million
Q4 2020 Feb 16, 2021	SELL	$4.87 - $17.29 $67,006 - $237,893	-13,759 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $956,011 - $1.71 Million	-63,396 Reduced 82.17%	13,759 $226,000
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $347,086 - $570,775	23,822 Added 44.67%	77,155 $1.8 Million
Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $542,718 - $1.12 Million	-52,845 Reduced 49.77%	53,333 $791,000
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $221,531 - $630,941	26,499 Added 33.26%	106,178 $2.17 Million
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $698,372 - $1.05 Million	-71,045 Reduced 47.14%	79,679 $783,000
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $628,436 - $1.01 Million	48,716 Added 47.76%	150,724 $2.03 Million
Q1 2019 May 15, 2019	BUY	$17.7 - $24.93 $1.54 Million - $2.17 Million	87,155 Added 586.78%	102,008 $2.01 Million
Q4 2018 Feb 14, 2019	BUY	$19.05 - $36.45 $282,949 - $541,391	14,853 New	14,853 $336,000
Q2 2018 Aug 14, 2018	SELL	$39.21 - $50.29 $251,414 - $322,459	-6,412 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $267,380 - $411,393	6,412 New	6,412 $315,000
Q4 2017 Feb 14, 2018	SELL	$28.58 - $49.91 $489,318 - $854,509	-17,121 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $395,152 - $597,865	17,121	17,121 $598,000

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$223,841
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $665M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account